AUDUBON, Pa., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will participate as a platinum sponsor at the North American Spine Society (NASS) Annual Meeting and Virtual Experience hosted online from October 6-9, 2020. Globus Medical’s participation at NASS includes webinars from surgeon experts featuring the latest clinical experiences using the company’s ExcelsiusGPSInterbody Solutions platform and minimally invasive expandable interbody technologies.
ExcelsiusGPS® Interbody Solutions is the latest module enhancement to the ExcelsiusGPS® robot-assisted spine surgery system that offers enhanced visualization, constant real-time feedback of dilation, disc prep, implant insertion, and the visibility to help achieve optimal implant placement. With this addition to today's most comprehensive robot-assisted spine surgery platform on the market, surgeons can now perform minimally invasive surgery using navigated implants from the most advanced expandable interbody portfolio on the market.
“As leaders in the musculoskeletal device industry, we are committed to supporting the research, education, and development of medical advancements through robotic spine surgery,” said Vice President of Product Development, Mark Adams. “We are proud to partner with NASS and are excited to showcase the strong utilization and clinical experience with our most recent product launches.”
Globus welcomes registered NASS surgeon attendees to view clinical presentations on Thursday October 8th.
Thursday, October 8th, 7:00-7:30PM CST
The Next Evolution of ExcelsiusGPS® Featuring Interbody Solutions
Sheeraz Quereshi, MD, MBA, Weill Cornell Medical College, New York, NY
Vladimir Sinkov, MD, Sinkov Spine Center, Las Vegas, NV
Thursday, October 8th, 7:30-8:00PM CST
Maximizing Lordosis with Posterior MIS Approaches
Choll W. Kim, MD, PhD, Spine Institute of San Diego, San Diego, CA
The company will also be hosting a virtual booth to showcase its most recent product innovations at GlobusMedical.com/VirtualBooth.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at http://www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, health epidemics, pandemics and similar outbreaks, including the COVID-19 pandemic, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Contact:
Brian Kearns
Senior Vice President, Business Development and Investor Relations
Phone: (610) 930-1800
Email: investors@globusmedical.com
www.globusmedical.com